-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Cyclacel Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q2 2023.
- Cyclacel Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2023 was 12.6M shares, a 23.8% increase year-over-year.
- Cyclacel Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 11.3M shares, a 26.1% increase from 2021.
- Cyclacel Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 8.93M shares, a 146% increase from 2020.
- Cyclacel Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 3.63M shares.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)